Perspectives of Internists and Surgeons on Borderline Resectable Hepatocellular Carcinoma: The Kanagawa Internists-Surgical Hepatocellular Carcinoma Treatment Collaboration Meeting Questionnaire

  • Watanabe Tsunamasa
    Department of Internal Medicine, Division of Gastroenterology and Hepatology, St. Marianna University School of Medicine
  • Taniai Nobuhiko
    Department of Gastroenterological Surgery, Nippon Medical School Musashikosugi Hospital
  • Endo Itaru
    Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine
  • Hidaka Hisashi
    Department of Gastroenterology, Internal Medicine, Kitasato University School of Medicine
  • Miura Fumihiko
    Dept. of Surgery, Teikyo University Hospital Mizunokuchi
  • Baba Toshiyuki
    Digestive Disease Center, Showa University Northern Yokohama Hospital
  • Takahashi Shinichiro
    Department of Gastroenterological Surgery, Tokai University School of Medicine
  • Nagahama Masatsugu
    Department of Internal, Medicine Division of Gastroenterology, Showa University Fujigaoka Hospital
  • Kumamoto Takafumi
    Gastroenterological Center, Yokohama City University Medical Center
  • Koizumi Satoshi
    Department of Gastroenterological and General Surgery, St. Marianna University School of Medicine
  • Yoneda Masato
    Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine
  • Enami Yuta
    Digestive Disease Center, Showa University Northern Yokohama Hospital
  • Kobayashi Satoshi
    Hepatobiliary and Pancreatic Medical Oncology, Kanagawa Cancer Center Hospital
  • Arase Yoshitaka
    Department of Internal Medicine, Division of Gastroenterology, Tokai University School of Medicine
  • Tanabe Tomohide
    Division of Gastroenterology, Nippon Medical School Musashikosugi Hospital
  • Matsumoto Kotaro
    Department of Gastroenterology, Teikyo University Hospital Mizunokuchi
  • Numata Kazushi
    Gastroenterological Center, Yokohama City University Medical Center

Bibliographic Information

Other Title
  • Borderline resectable HCCに対する内科と外科の考え方:“神奈川内科―外科HCC治療連携meeting”アンケート調査より
  • Borderline resectable HCC ニ タイスル ナイカ ト ゲカ ノ カンガエカタ : "カナガワ ナイカ-ゲカ HCC チリョウ レンケイ meeting"アンケート チョウサ ヨリ

Search this article

Description

<p>A 30-question questionnaire survey was administered to 45 full-time surgeons board-certified by the Japanese Society of Hepatobiliary Surgery and internists board-certified by the Japanese Society of Gastroenterology or the Japan Society of Hepatology practicing in Kanagawa Prefecture. Responses to questions on the criteria for liver resection and multidisciplinary treatment of hepatocellular carcinoma were collected from 69 participants, including 41 internists and 28 surgeons, from 28 centers. Regarding the decision for surgical hepatocellular carcinoma resection after medical treatment, except in the down stage, the internists focused on achieving complete response whereas the surgeons focused on achieving no recurrence for a certain duration. In patients responding to medical treatment, internists were more likely to continue medical treatment and only chose resection if the tumor shrank with a change in response from Vp4 to Vp2, which was lower than the surgeon's resection selection rate. For multidisciplinary treatment, the recognition matching of both medical and surgical according to common criteria by the cancer board was important.</p>

Journal

  • Kanzo

    Kanzo 66 (4), 125-139, 2025-04-01

    The Japan Society of Hepatology

Details 詳細情報について

Report a problem

Back to top